Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some...
February 3, 2026
360
1
5
1.67%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around February 3, 2026
See what was published immediately before and after this episode.
4:40Now PlayingPfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some...
YouTube Description
as posted by the channelToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.
- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share. The stock fell as much as 3.2% in pre-market trading.
- Snacks and beverage company PepsiCo (PEP) reported better-than-expected fourth-quarter profit, buoyed by strong international demand, and announced a $10 billion share buyback.New York-based PepsiCo, which owns brands such as Lay’s and Gatorade, posted earnings per share of $2.26, slightly ahead of Wall Street estimates.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.